Tredje AP fonden raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 134,301 shares of the healthcare conglomerate’s stock after buying an additional 4,000 shares during the period. UnitedHealth Group makes up 1.1% of Tredje AP fonden’s portfolio, making the stock its 17th biggest position. Tredje AP fonden’s holdings in UnitedHealth Group were worth $52,477,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of UnitedHealth Group during the second quarter worth approximately $28,000. Activest Wealth Management acquired a new stake in shares of UnitedHealth Group during the second quarter worth approximately $29,000. Tompkins Financial Corp bought a new position in UnitedHealth Group during the third quarter valued at approximately $32,000. Finally, Annapolis Financial Services LLC raised its position in UnitedHealth Group by 57.9% during the third quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 33 shares in the last quarter. 86.10% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Tuesday, November 23rd. The stock was sold at an average price of $444.70, for a total transaction of $1,111,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction that occurred on Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The disclosure for this sale can be found here. Corporate insiders own 0.55% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The firm had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business posted $3.51 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th were paid a $1.45 dividend. The ex-dividend date of this dividend was Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.
UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research report on Tuesday, November 16th. Sanford C. Bernstein lifted their price target on shares of UnitedHealth Group from $508.00 to $564.00 in a research note on Tuesday. Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $478.00 to $520.00 and gave the stock an “overweight” rating in a research note on Monday, October 25th. UBS Group boosted their target price on shares of UnitedHealth Group from $435.00 to $452.00 and gave the company a “neutral” rating in a research note on Wednesday, December 1st. They noted that the move was a valuation call. Finally, The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, December 14th. They issued a “buy” rating and a $535.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $500.54.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Recommended Story: 52-week highs
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.